46.46.Z - Wholesale trade of pharmaceutical and medical products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
46.69.Z - Wholesale trade
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
82.11.Z - Office administrative support activities and other business support services
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,5 | -0,7 | -0,3 | 63,3 |
EBITDA | -0,5 | -0,7 | -0,2 | 76,8 |
Short time liabilities | 3,5 | 4,4 | 5,3 | 20,3 |
Equity capital | -1,9 | -2,6 | -2,9 | -9,9 |
Operating profit (EBIT) | -0,5 | -0,7 | -0,2 | 68,6 |
Assets | 1,7 | 1,9 | 2,6 | 35,9 |
Net profit (loss) | -0,5 | -0,7 | -0,3 | 63,3 |
Cash | 0,3 | 0,3 | 7,2 | |
Liabilities and provisions for liabilities | 3,6 | 4,5 | 5,5 | 21 |
Net income from sale | 2,5 | 2,9 | 5 | 75,1 |
Working assets | 1,7 | 1,9 | 2,2 | 13,3 |
Depreciation | 0 | 0 | 0,1 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 28 | 26,9 | 9 | -17,9 |
Equity capital to total assets | -113,6 | -135,3 | -109,3 | 26 |
Gross profit margin | -21,7 | -24,5 | -5,1 | 19,4 |
EBITDA Margin | -21 | -24,5 | -3,2 | 21,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 525 | 566 | 389 | -177 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane